Blog
Featured Blogger
The week of October 10, 2013, the periodical Diabetologia published the surprising results of a study recently completed in the field of type 1 diabetes research. Once released, it quickly made headlines around the world. The noteworthy research was conducted by a series of professionals affiliated with the National Institute for Health Research Exeter Clinical Research Facility. It is located at the University of Exeter Medical School in the United Kingdom. One of the lead researchers involved with the study was Dr. Richard A. Oram. The venerable Dr. Oram and his cohorts studied 74 participants in the hopes of obtaining additional information on C-peptides and insulin production in type 1 diabetics. They tested the subjects using ultrasensitive assays over a period of several years. What they uncovered as a result of that testing was quite stunning. They determined that contrary to long held beliefs, type 1 diabetics’ bodies do continue to produce insulin via beta cells. However, those insulin levels…
Published in
General
For those who have diabetes, lancets are a way of life. Individuals who may be shy about drawing blood initially eventually realize the process is life saving and learn to complete the process alone. When a lancet or lancing device is cared for properly, there is very little that can go wrong. The Difference Between a Lancet and a Lancing Device A lancet is for one time use. If a single lancet is used repeatedly, the needle will become dull and will hurt. A lancing device includes a lancet which needs to be changed daily, but does not need to be changed after every use. Diabetics who test more than once a day prefer lancing devices. General Care of a Lancet or Lancing Device New diabetics may not understand how to care for a lancet or lancing device. If a lancet is used, it needs to be disposed of correctly to avoid harm to others. Diabetics need to speak with…
Published in
Diabetes Products
29Dec
Diabetes Testing Supplies’ News: Artificial Pancreas Device Given the Green Light
Written by Editor
On September 27, 2013, national headlines were filled with news about a recent advancement in the treatment of diabetes. It was an advancement that those in the healthcare industry have been fervently working on for years. The diabetes treatment making all of the recent headlines is Medtronic’s APDS, also known as the MiniMed530G. It is an artificial pancreas device system that the company finally received partial U.S. FDA approval on in September. The approval enables the system to be used with adult populations. The company is hoping to expand upon that approval in the future to include juveniles under the age of 16. At this point, the product itself is anticipated to be available for purchase in the coming weeks. The company’s new system consists of a CGM integrated insulin pump that has been outfitted with a hypersensitive glucose sensor, bolus wizard, automatic alerts and a preset, threshold suspension feature. Because of those features, it is said to be helpful…
Published in
General
Advanced Diabetes Supply
- 2544 Campbell Place, Suite 150
Carlsbad, CA 92009 - 1-866-422-4866
- 1-800-503-6280
- Contact Us
Living With Erectile Dysfunction
Diabetes Testing Supplies: A Look at Hypoglycemia Sleep Alarms
Diabetes Testing Supplies May Help People Avoid Episodes of Ketoacidosis